Regen BioPharma Inc (RGBP)

[bigtalan]

As of March 31, 2023 the Company is indebted to David R. Koos the Company’s sole officer and director in the amount of $710. $710 lent to the Company by Koos is due and payable at the demand of the holder and bear simple interest at a rate of 15% per annum. Very interesting you have 87k on hand but you have to be lent 710 by the CEO at 15%, makes sense to me

On January 13, 2022 Regen Biopharma, Inc. entered into a sublease agreement with BST Partners (“BST”) whereby Regen Biopharma, Inc. would sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 from BST on a month to month basis for $5,000 per month beginning January 14, 2022. Rent to another company you own makes sense to me

BST Partners is controlled by David Koos who serves as the sole officer and director of Regen Biopharma, Inc.

As of March 31, 2023 we had $87,700 in cash on hand and current liabilities of $5,336,389. We feel we will not be able to satisfy our cash requirements over the next twelve months and shall be required to seek additional financing. You just stoled 4.977Billion shares and you still owe people money gotta love it .

As of March 31, 2023 the Company was not party to any binding agreements which would commit Regen to any material capital expenditures.
IMO GLTA